Gemphire Therapeutics Probability of Future Stock Price Finishing Under 2.39
Gemphire Therapeutics' future price is the expected price of Gemphire Therapeutics instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Gemphire Therapeutics performance during a given time horizon utilizing its historical volatility. Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.
Please specify Gemphire Therapeutics' target price for which you would like Gemphire Therapeutics odds to be computed.
Gemphire |
Gemphire Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Gemphire Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Gemphire Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Gemphire Therapeutics is not yet fully synchronised with the market data | |
| Gemphire Therapeutics has some characteristics of a very speculative penny stock | |
| Gemphire Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company has a current ratio of 0.66, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Gemphire Therapeutics until it has trouble settling it off, either with new capital or with free cash flow. So, Gemphire Therapeutics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Gemphire Therapeutics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Gemphire to invest in growth at high rates of return. When we think about Gemphire Therapeutics' use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (13.81 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Gemphire Therapeutics currently holds about 1.85 M in cash with (10.94 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.12. | |
| Roughly 56.0% of the company shares are held by company insiders |
Gemphire Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Gemphire Stock often depends not only on the future outlook of the current and potential Gemphire Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Gemphire Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Average Daily Volume Last 10 Day | 7.64k | |
| Average Daily Volume In Three Month | 7.64k |
Gemphire Therapeutics Technical Analysis
Gemphire Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Gemphire Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Gemphire Therapeutics. In general, you should focus on analyzing Gemphire Stock price patterns and their correlations with different microeconomic environments and drivers.
Gemphire Therapeutics Predictive Forecast Models
Gemphire Therapeutics' time-series forecasting models is one of many Gemphire Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Gemphire Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Gemphire Therapeutics
Checking the ongoing alerts about Gemphire Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Gemphire Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Gemphire Therapeutics is not yet fully synchronised with the market data | |
| Gemphire Therapeutics has some characteristics of a very speculative penny stock | |
| Gemphire Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company has a current ratio of 0.66, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Gemphire Therapeutics until it has trouble settling it off, either with new capital or with free cash flow. So, Gemphire Therapeutics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Gemphire Therapeutics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Gemphire to invest in growth at high rates of return. When we think about Gemphire Therapeutics' use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (13.81 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Gemphire Therapeutics currently holds about 1.85 M in cash with (10.94 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.12. | |
| Roughly 56.0% of the company shares are held by company insiders |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Consideration for investing in Gemphire Stock
If you are still planning to invest in Gemphire Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Gemphire Therapeutics' history and understand the potential risks before investing.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |